BRPI0415023A - derivados de triterpenos inusitados, sua preparação e seu uso - Google Patents

derivados de triterpenos inusitados, sua preparação e seu uso

Info

Publication number
BRPI0415023A
BRPI0415023A BRPI0415023-6A BRPI0415023A BRPI0415023A BR PI0415023 A BRPI0415023 A BR PI0415023A BR PI0415023 A BRPI0415023 A BR PI0415023A BR PI0415023 A BRPI0415023 A BR PI0415023A
Authority
BR
Brazil
Prior art keywords
preparation
unusual
derivatives
triterpene derivatives
triterpene
Prior art date
Application number
BRPI0415023-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Carl T Wild
Gary N Robinson
Mark Ashton
Thomas Russell
Original Assignee
Panacos Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacos Pharmaceuticals Inc filed Critical Panacos Pharmaceuticals Inc
Publication of BRPI0415023A publication Critical patent/BRPI0415023A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/40Succinic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/42Glutaric acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/608Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/52Ortho- or ortho- and peri-condensed systems containing five condensed rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0415023-6A 2003-09-26 2004-09-27 derivados de triterpenos inusitados, sua preparação e seu uso BRPI0415023A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50589903P 2003-09-26 2003-09-26
US55935804P 2004-04-05 2004-04-05
PCT/US2004/031370 WO2005030790A1 (en) 2003-09-26 2004-09-27 Novel triterpene derivatives, preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
BRPI0415023A true BRPI0415023A (pt) 2006-11-07

Family

ID=34396277

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415023-6A BRPI0415023A (pt) 2003-09-26 2004-09-27 derivados de triterpenos inusitados, sua preparação e seu uso

Country Status (10)

Country Link
US (1) US20050148561A1 (https=)
EP (1) EP1675866A1 (https=)
JP (1) JP2007506761A (https=)
KR (1) KR20060096147A (https=)
AU (1) AU2004276307A1 (https=)
BR (1) BRPI0415023A (https=)
CA (1) CA2540160A1 (https=)
IL (1) IL174317A0 (https=)
NO (1) NO20061792L (https=)
WO (1) WO2005030790A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1730163A4 (en) * 2004-03-17 2009-12-30 Panacos Pharmaceuticals Inc Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
EP1868613B1 (en) * 2005-04-12 2012-03-07 Myrexis, Inc. Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine
EP1893629A4 (en) * 2005-06-22 2008-12-17 Myriad Genetics Inc ANTIVIRAL CONNECTIONS
GB0604899D0 (en) * 2006-03-10 2006-04-19 York Pharma Plc Derivatives of 18-glycyrrhetinic acid
US20080039428A1 (en) * 2006-06-29 2008-02-14 Panacos Pharmaceuticals, Inc. Antiretroviral combination therapy
WO2008115281A2 (en) * 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
AR063546A1 (es) 2006-11-03 2009-01-28 Panacos Pharmaceuticals Inc DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH.
WO2008146305A2 (en) * 2007-06-01 2008-12-04 Council Of Scientific & Industrial Research A pharmaceutical composition having virucidal and spermicidal activity
KR100941595B1 (ko) * 2008-06-05 2010-02-11 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 트리테르페노이드계 화합물
CN102532245B (zh) * 2011-12-31 2013-05-15 中国人民解放军第三军医大学 一种熊果酸衍生物及其制备方法
EP3565527A4 (en) * 2017-01-05 2019-12-18 Regents of the University of California CONTRIBUTIVE USE OF TRITER PENOIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1415601A (en) * 1973-03-14 1975-11-26 Biorex Laboratories Ltd Dihydrobetulinic acid derivatives
AU2001294953A1 (en) * 2000-09-29 2002-04-08 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast

Also Published As

Publication number Publication date
KR20060096147A (ko) 2006-09-07
EP1675866A1 (en) 2006-07-05
AU2004276307A1 (en) 2005-04-07
US20050148561A1 (en) 2005-07-07
CA2540160A1 (en) 2005-04-07
IL174317A0 (en) 2006-08-01
WO2005030790A1 (en) 2005-04-07
NO20061792L (no) 2006-06-14
JP2007506761A (ja) 2007-03-22

Similar Documents

Publication Publication Date Title
YU51095A (sh) Benzokazolil - i benzotiazolil-oksazo lidinoni
BR0111667A (pt) Novos compostos
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
DOP2001000297A (es) Nuevas imidazotriazinonas sustituidas
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BR9804815A (pt) "composições antimicrobianas"
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
BRPI0408347A (pt) derivados de pirimidina
BR9801652A (pt) Resorcinil-triazinas
MX9700885A (es) Nuevas heteroariloxazolidinonas.
BRPI0415023A (pt) derivados de triterpenos inusitados, sua preparação e seu uso
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
UY28312A1 (es) Pirazolopirimidinas sustituidas con 6-ciclimetilo y 6-alquilmetilo
BRPI0112452B8 (pt) derivados de pleuromutilinas tendo atividade antibacteriana e composição farmacêutica contendo os mesmos
BR0111669A (pt) Novos compostos
BRPI0412744A (pt) derivados de combretastatina com ação citotóxica
YU4497A (sh) Novi heteroaril - oksazolidinoni
CR6693A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
BR0010499A (pt) Agentes endoparasiticidas
BR9913107A (pt) Derivados de benzoilguanidina, com propriedades vantajosas, processos para sua preparação e seu uso na produção de medicamentos
AR023374A1 (es) Derivados de 3-amino-3-arilpropano-1-ol. su preparacion y uso
AR009322A1 (es) Nuevas aril-piridazinas
BR0008563A (pt) Sistemas policìclicos de 2-amino-dihidrotiazol, processo para a sua preparação e seu uso como medicamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.